| ¿µ¹® | neurofibromatosis | ÇÑ±Û | ½Å°æ¼¶À¯Á¾Áõ |
|---|---|---|---|
| ¼³¸í | Àü½ÅÀÇ ¿©·¯°÷¿¡ ¹«´õ±â·Î ³ª´Â ½Å°æ¼¶À¯Á¾À» Ư¡À¸·Î ÇÏ´Â À¯Àü¼º Àü½Å º´. ¸»ÃÊ ½Å°æ»Ó ¾Æ´Ï¶ó ÁßÃß ½Å°æ°èµµ ħ¹üÇÒ ¼ö ÀÖ´Ù. ½Å°æ¼¶À¯Á¾Àº ÁÖ·Î Àü½ÅÀÇ ÇǺο¡ ¹ß»ýµÇÁö¸¸ ½Å°æ¾ó±â ȤÀº ³»Àå¿¡ »ý±â´Â ¼öµµ ÀÖ´Ù. ÇǺο¡´Â ¶ÇÇÑ °÷°÷¿¡ ƯÀ¯ÀÇ °¥»ö»ö¼Ò¹ÝÀ» º¸°Ô µÈ´Ù. °ñ°ÝÀÇ º¯ÇüÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ½Å°æÃÊÁ¾À̳ª ¾Ç¼º½Å°æÃÊÁ¾, ´õ¿íÀÌ ½Å°æ±³Á¾À̳ª ¼ö¸·Á¾ µîÀÇ µÎ°³³»Á¾¾çÀ» ÇÕº´ÇÔµµ ¾Ë·ÁÁ® ÀÖ´Ù. 1Çü(von Recklinghausen º´, ÀüÇüÀû ½Å°æ¼¶À¯Á¾Áõ)°ú 2Çü(ÁßÃßÇü ¶Ç´Â û°¢½Å°æ¼¶À¯Á¾Áõ)À¸·Î ±¸ºÐÇÑ´Ù. ÀüÇüÀû ½Å°æ¼¶À¯Á¾Áõ(1Çü)ÀÌ °¡Àå ¸¹ÀÌ ¹ß»ýÇÏ¸ç ´ÙÀ½°ú °°Àº 3°¡Áö ¼Ò°ßÀ» º¸Àδô. Áï ¨ç üǥ¸é, ü³» ¿©·¯ °÷¿¡ »êÀçµÇ¾î ¹ß»ýÇÏ´Â ¾ó±â¸ð¾ç½Å°æÁ¾, ¨è ¿ìÀ¯Ä¿ÇǹÝÁ¡, ¨é ¸®½¬(Lisch) °áÀý·Î ºÒ¸®´Â ȫäÀÇ Âø»ö°ú¿ÀÁ¾ÀÌ´Ù. 2ÇüÀº 1Çüº¸´Ù ¹ß»ýºóµµ°¡ Àû°í, Ư¡ÀûÀ¸·Î ¾çÂʼº û°¢½Å°æÁ¾ÀÌ ÀÖÀ¸¸ç, ¿ìÀ¯¹ÝÁ¡Àº º¸À̳ª ¸®½¬°áÀýÀº ¾ø´Ù. |
||
| NF | nafcillin; National Formulary; nephritic factor; neurofibromatosis; neurofilament; neutral fraction;... |
|---|---|
| NF1 | neurofibromatosis type I; nuclear factor 1 |
| NF2 | neurofibromatosis type II |
| NFNS | neurofibromatosis-Noonan syndrome |
| NPDC | neurofibromatosis-pheochromocytoma-duodenal carcinoid [syndrome] |
| FIA | Freund incomplete adjuvant |
|---|---|
| IFA | Incomplete Freund Adjuvant |
| IR | Incomplete Repair |
| NF1 | NEUROFIBROMATOSIS TYPE 1 |
| NF | Neurofibromatosis |
| abortive neurofibromatosis | incomplete neurofibromatosis |
|---|---|
| genes, neurofibromatosis 1 | Tumour suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause neurofibromatosis 1. (12 Dec 1998) |
| genes, neurofibromatosis 2 | Tumour suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes neurofibromatosis 2. (12 Dec 1998) |
| central type neurofibromatosis | Type I neurofibromatosis. Incomplete neurofibromatosis, multiple neurofibromas with minimal manifestations, perhaps limited to cafe-au-lait spots; individuals with minimal lesions may have offspring with severe involvement. Synonym: abortive neurofibromatosis. (05 Mar 2000) |
| neurofibromatosis | <oncology> One of the most common disorders in genetics, neurofibromatosis encompasses at least two diseases, designated NF-1 and NF-2. NF-1 or classic neurofibromatosis, is characterised by the familiar cafe- au-lait spots, axillary freckling, cutaneous and visceral neurofibromas (which sometimes undergo malignant transformation), gliomas, scoliosis, and Lisch nodules of the iris. NF-1 is associated with the the von Recklinghausen Neurofibromatosis locus that encodes the NF-1 protein, a GTPase activating protein which interacts with the ras proteins. The gene is located on chromosome 17. NF-2, also called acoustic or central neurofibromatosis, features neurofibromas restricted to the acoustic nerve (usually bilateral) and the central nervous system, skin lesions may or may not be present. The gene is located on chromosome 22. There are no biochemical markers of the disorder, but the cloning of both the NF-1 and NF-2 genes makes DNA-based diagnosis possible in some families. Both genes appear to be tumour suppressor genes. Both conditions are autosomal dominant, but the variable penetrance and expressivity and high frequency of new mutations make genetic counseling difficult. Inheritance: autosomal dominant. (29 Dec 1997) |
| neurofibromatosis 1 | A congenital autosomal dominant disorder characterised by developmental changes in the nervous system, muscles, bones, and skin especially in those derived from the embryonic neural crest. There are multiple cutaneous tumours and tumours of the peripheral and central nervous system. The disease has been linked to mutations of the nf1 gene on chromosome 17. (12 Dec 1998) |
| neurofibromatosis 2 | Severe autosomal dominant disorder characterised especially by bilateral acoustic neuromas as well as other multiple tumours including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the nf2 gene on chromosome 22. (12 Dec 1998) |
| abortion, incomplete | Abortion in which not all the products of conception have been expelled. (12 Dec 1998) |
| incomplete | 1. Not complete; not filled up; not finished; not having all its parts, or not having them all adjusted; imperfect; defective. "A most imperfect and incomplete divine." (Milton) 2. <botany> Wanting any of the usual floral organs; said of a flower. <mathematics> Incomplete equation, an equation some of whose terms are wanting; or one in which the coefficient of some one or more of the powers of the unknown quantity is equal to 0. Origin: L. Incompletus: cf. F. Incomplet. See In- not, and Complete. Source: Websters Dictionary (01 Mar 1998) |
| incomplete abortion | <obstetrics> A clinical situation where the foetus has died but has not been completely expelled from the uterus. (13 Nov 1997) |
| incomplete achromatopsia | Impaired, but not absent, colour vision with less severely reduced visual acuity than in complete achromatopsia; inherited as an autosomal recessive or as an X-linked disorder (blue cone monochromism; pi cone monochromatism ). (05 Mar 2000) |
| incomplete agglutinin | Antibody that binds to antigen but does not induce agglutination. These antibodies are usually of the IgG class and are referred to as incomplete antibody. (05 Mar 2000) |
| incomplete alexia | <clinical sign> A term used to describe a condition in which an individual with normal vision is unable to properly interpret written language. Dyslexia is more common in males and is often first recognised as a reading difficulty in the first grade. Individuals can see and recognise letters but are unable to spell and write words. They have no impairment of object or picture identification. Dyslexia is not related to intelligence and in fact several famous scholars were thought to be dyslexic (for example Albert Einstein, Thomas Edison). The exact cause of dyslexia is unknown. (27 Sep 1997) |
| incomplete antibody | An "incomplete" form of antibody that may coat antigen, but which according to the "lattice theory" does not have a second receptor for attachment to another molecule of antigen; in the case of Rh+ erythrocytes, such an anti-Rh antibody may coat the cells but not cause them to agglutinate in saline; however, agglutination does occur when such coated cells are suspended in serum or other protein media, such as albumin, therefore called serum agglutinin. Synonym: incomplete antibody, inhibiting antibody. (05 Mar 2000) |
| incomplete antigen | <immunology, molecular biology> Could be considered an isolated epitope: although a hapten (by definition) has an antibody directed against it, the hapten alone will not induce an immune response if injected into an animal, it must be conjugated to a carrier (usually a protein). The hapten constitutes a single antigenic determinant, perhaps the best known example is dinitro phenol (DNP) that can be conjugated to BSA and against which antiDNP antibodies are produced (antibodies to the BSA can be adsorbed out). Because the hapten is monovalent, immune complex formation will be blocked if the soluble hapten is present as well as the hapten carrier conjugate (assuming there is more than one hapten per carrier then an immune precipitate can be formed). Competitive inhibition by the soluble small molecule is sometimes referred to as haptenic inhibition and this term has carried over into lectin mediated haemagglutination where monosaccharides are added to try to block haemagglutination: the blocking sugar defines the specificity of the lectin. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|